Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALL
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
AQUASTRONG Unveils Comprehensive Pool Circulation System Solutions: From Filtration to Heating
HONG KONG, Dec. 10, 2024 /PRNewswire/ -- AQUASTRONG today announced the launch of its upgraded pool circulation system solutions, further expanding its product line to meet the diverse needs of pool users. Leveraging innovative technology and an...
Vodafone Idea selects Tejas Networks to scale its backhaul capacity for 4G and 5G rollouts
BENGALURU, India, Dec. 10, 2024 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE: TEJASNET) today announced that it has entered into a three - year contract with Vodafone Idea Limited ("VIL"), a leading telecom service provider in India, to supply...
KONJAKUSO by Funbound Co., Ltd. Now Offers Luxury and Premium Rental Properties on Homes & Villas by Marriott Bonvoy
YASU and OSAKA, Japan, Dec. 10, 2024 /PRNewswire/ -- Funbound Co., Ltd., a company that specializes in the renovation of vacant houses and buildings into high-end private lodgings under the KONJAKUSO brand, announced that select rental properties...
Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024
SHANGHAI and HONG KONG, Dec. 10, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing...
NTT Group Chooses Evidian Identity Governance & Administration as the Cornerstone of their Identity Management Infrastructure in Japan
One of the largest IGA deployments in Japan, ensuring governance and scalability for identity and rights management for 250 000 employees within the NTT Group PARIS, Dec. 10, 2024 /PRNewswire/ -- Eviden, the Atos Group business leading in digital,...
SS&C Signs Agreement with Insignia Financial
WINDSOR, Conn., Dec. 10, 2024 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced an initial agreement with Insignia Financial (Insignia) to deliver superannuation member administration services. Insignia Financial...
Adoption of an Exclusive Human Milk Diet Reduces Malnutrition Rates Among Vulnerable Premature Infants in Sydney Hospital
Preliminary Data From Observational Study Presented at Australian and New Zealand Neonatal Network Clinical Practice Improvement Conference ADELAIDE, Australia, Dec. 10, 2024 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital...
2024 ESMO Asia: TransThera announces clinical data of tinengotinib in combination with atezolizumab (PD-L1) in biliary tract carcinoma (BTC)
NANJING, China and GAITHERSBURG, Md., Dec. 9, 2024 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced the poster presentation at the 2024 European Society For Medical Oncology (ESMO) Asia Congress to discuss the clinical...